Condition: Post-mastectomy Pain Syndrome · Breast Cancer · Pain, Postoperative · Sponsor: University Health Network, Toronto
Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
This description comes directly from the study's public registry record.
James Khan · 416-340-4800 · James.Khan@medportal.ca
Nour Ayach · 416-340-4800 · Nour.Ayach@uhn.ca
Always discuss trial participation with your own doctor first.
| Foothills Medical Centre | Calgary, Alberta, Canada | Recruiting |
| Sturgeon Community Hospital | Edmonton, Alberta, Canada | Recruiting |
| Eastern Health- Health Sciences Centre | St. John's, Newfoundland and Labrador, Canada | Recruiting |
| IWK | Halifax, Nova Scotia, Canada | Recruiting |
| Juravinski Hospital | Hamilton, Ontario, Canada | Recruiting |
| North York General Hospital | North York, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| Thunder Bay Regional Health Sciences Centre | Thunder Bay, Ontario, Canada | Recruiting |
| Humber River Hospital | Toronto, Ontario, Canada | Recruiting |
| Mount Sinai Hospital | Toronto, Ontario, Canada | Recruiting |
| St. Michael's Hospital | Toronto, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04874038